This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.
Neurobiology of disease, 124, 439-453
Citation
Bader, Miaad; Li, Yazhou; Lecca, Daniela; Rubovitch, Vardit; Tweedie, David; Glotfelty, Elliot; Rachmany, Lital; Kim, Hee Kyung; Choi, Ho-Il; Hoffer, Barry J; Pick, Chaim G; Greig, Nigel H; Kim, Dong Seok. (2019). Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.. Neurobiology of disease, 124, 439-453. https://doi.org/10.1016/j.nbd.2018.11.023